All Stories

  1. In Silico Analysis of Drug Repurposing Strategy for the Identification of Potential NS3 Helicase Inhibitors Against Zika Virus
  2. Isolation of Natural Compounds from Syzygium densiflorum Fruits and Exploring its Chemical Property, Therapeutic Role in Diabetic Management
  3. Current Scenario in Structure and Ligand-Based Drug Design on Anti-colon Cancer Drugs
  4. Inhibitory potential of Hydroxychavicol on Ehrlich ascites carcinoma model and in silico interaction on cancer targets
  5. In silico insights on Tankyrase protein: a potential target for colorectal cancer
  6. Identification of Direct Renin Inhibitors
  7. Atom-based and Pharmacophore-based 3D – QSAR Studies on Vitamin D Receptor (VDR)
  8. In silico identification and screening of CYP24A1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis
  9. Design, synthesis, and characterization of α, β-unsaturated carboxylic acid, and its urea based derivatives that explores novel epigenetic modulators in human non-small cell lung cancer A549 cell line
  10. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells
  11. Understanding the Evolutionary Relationship of M2 Channel Protein of Influenza A Virus and its Structural Variation and Drug Resistance
  12. The Binding Mode Prediction and Similar Ligand Potency in the Active Site of Vitamin D Receptor with QM/MM Interaction, MESP, and MD Simulation
  13. Renin Angiotensin System Gene Polymorphisms in Response to Antihypertensive Drugs and Visit-To-Visit Blood Pressure Variability in Essential Hypertensive Patients
  14. Computational Insights into the Inhibition of Influenza Viruses by Rupestonic Acid Derivatives: Pharmacophore Modeling, 3D-QSAR, CoMFA and COMSIA Studies
  15. Zn2+ion of the snake venom metalloproteinase (SVMP) plays a critical role in ligand binding: a molecular dynamics simulation study
  16. Sighting of tankyrase inhibitors by structure- and ligand-based screening and in vitro approach
  17. Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions
  18. Jak2 inhibitor – a jackpot for pharmaceutical industries: a comprehensive computational method in the discovery of new potent Jak2 inhibitors